However, this hypothesis was not verified in our CLL model, which, to restore BUB1 expression, uses another mechanism or rather increases the expression of the RNA binding protein HNRNPL, which binds the BUB1 3′UTR and impairs miR-155 targeting. This evidence concerns the gene HNRNPL and B-cell chronic lymphocytic leukemia.